More and more people in Europe are turning to CBD to treat their medical symptoms. CBD is considered as the new ‘wonder drug’ of the 21st century, with many articles and research studies suggesting a lots of different treatment options.
CBD products are being widely used by both adults and children. People use it from things like anxiety to epilepsy and even cancer. In the past few years, with groundbreaking cases like that of Charlotte’s web, the whole industry has been growing really fast. The acceptance and popularity of CBD products is following pretty much the same path. Finally all these changes are slowly transforming how people think about CBD products, and about hemp and cannabis in general.
Another interesting fact is, that over 42% of CBD users nowadays have ditched pharmaceutical drugs in favour of CBD. However, the legal and medical status of cannabis and CBD products can be somewhat confusing and often hard to navigate, as it all depends on their definitions.
So is There any Medical Evidence that CBD Works?
To be able to answer, first you need to know what medical evidence really means: “The judicious use of the best current available scientific research in making decisions about the care of patients. Evidence-based medicine (EBM) is intended to integrate clinical expertise with research evidence and patient values.”
Up until now, medical research into cannabidiol and its beneficial effects have been few and far between. Currently there has been around 47 clinical studies and case reports about the compound cannabidiol for medical use. Some studies date back to the 1980’s, when the effects of CBD were first explored in epileptic patients
In the recent years there has been a significant rise in clinical studies and case reports. In 2018 alone there were 11 clinical studies worldwide that were related to cannabidiol for medical use, although not all tests were carried out on humans. The good thing about all this is, that even if we are not there yet, we are getting closer to the point, where it might be recognised as a medical treatment.
Studies about the use of CBD in the past few years have been focused mainly on epilepsy. In exciting news for CBD watchers, there is a brand new cannabidiol-based drug in the pipeline that is set to change the ambiguity that surrounds whether CBD really works or not.
The most recent study on humans is about the effects of CBD on children with Dravet syndrome. This rare condition causes epileptic seizures when the child becomes sick or excited.
Epidiolex is set to be the first plant-derived cannabidiol drug to gain FDA approval. Before this, CBD hasn’t been used by the medical profession, even though there is a long list of symptoms users claim CBD has been beneficial in treating. Over the decades, medical tests have focused more broadly on the effects of cannabis and THC for medical use, and very few have looked specifically at the CBD compound.
In 2017, a study was published on the effects of CBD on rodents that had Dravet syndrome. Results showed a significant change in the frequency and strength of seizures. These results were so promising that scientists then went on to conduct human trails, and they don’t just do that for any old drug (most animal testing trials aren’t continued into humans).
In a sample of 214 children aged between 2 and 18 with Dravet syndrome, the results found that children who took CBD experienced significantly fewer seizures than the children that took the placebo drug. In fact, 5% of patients stopped having seizures completely.